Arduini Peter J.'s most recent trade in GE HealthCare Technologies Inc was a trade of 5,874 Common Stock, par value $0.01 per share done at an average price of $73.7 . Disclosure was reported to the exchange on Sept. 1, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| GE HealthCare Tech | Peter J. Arduini | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.73 per share. | 01 Sep 2025 | 5,874 | 173,354 | - | 73.7 | 433,090 | Common Stock, par value $0.01 per share |
| GE HealthCare Tech | Peter J. Arduini | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.73 per share. | 01 Sep 2025 | 5,472 | 167,882 | - | 73.7 | 403,451 | Common Stock, par value $0.01 per share |
| Bristol-Myers Squibb | Peter J. Arduini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2025 | 729 | 62,988 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb | Peter J. Arduini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2025 | 553 | 61,491 | - | - | Deferred Share Units | |
| GE HealthCare Tech | Peter J. Arduini | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 119,913 | 119,913 | - | - | Employee Stock Option (right to buy) | |
| GE HealthCare Tech | Peter J. Arduini | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 41,931 | 179,228 | - | 0 | Common Stock, par value $0.01 per share | |
| GE HealthCare Tech | Peter J. Arduini | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.35 per share. | 01 Mar 2025 | 29,818 | 137,297 | - | 87.3 | 2,604,602 | Common Stock, par value $0.01 per share |
| GE HealthCare Tech | Peter J. Arduini | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 87.35 per share. | 01 Mar 2025 | 4,507 | 167,115 | - | 87.3 | 393,686 | Common Stock, par value $0.01 per share |
| GE HealthCare Tech | Peter J. Arduini | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2025 | 67,487 | 171,622 | - | 0 | Common Stock, par value $0.01 per share | |
| Bristol-Myers Squibb | Peter J. Arduini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2025 | 3,562 | 60,937 | - | - | Deferred Share Units | |
| GE HealthCare Tech | Peter J. Arduini | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 88.30 per share. | 01 Feb 2025 | 3,206 | 104,135 | - | 88.3 | 283,090 | Common Stock, par value $0.01 per share |
| Bristol-Myers Squibb | Arduini Peter J. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2024 | 596 | 56,788 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb | Peter J. Arduini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2024 | 652 | 55,577 | - | - | Deferred Share Units | |
| GE HealthCare Tech | Peter J. Arduini | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 84.82 per share. | 01 Sep 2024 | 5,859 | 107,341 | - | 84.8 | 496,960 | Common Stock, par value $0.01 per share |
| Bristol-Myers Squibb | Peter J. Arduini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2024 | 825 | 54,249 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb | Peter J. Arduini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2024 | 645 | 52,708 | - | - | Deferred Share Units | |
| GE HealthCare Tech | Peter J. Arduini | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 103,527 | 103,527 | - | - | Employee Stock Option (right to buy) | |
| GE HealthCare Tech | Peter J. Arduini | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 36,399 | 113,200 | - | 0 | Common Stock, par value $0.01 per share | |
| GE HealthCare Tech | Peter J. Arduini | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 91.28 per share. | 01 Mar 2024 | 4,444 | 76,801 | - | 91.3 | 405,648 | Common Stock, par value $0.01 per share |
| Bristol-Myers Squibb | Arduini J. Peter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2024 | 4,314 | 52,063 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb | J. Arduini Peter | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2023 | 657 | 47,167 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb | Peter J. Arduini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2023 | 581 | 45,997 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb | Peter J. Arduini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 527 | 44,999 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb | Peter J. Arduini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2023 | 486 | 44,104 | - | - | Deferred Share Units | |
| GE HealthCare Tech | Peter J. Arduini | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 109,994 | 109,994 | - | - | Employee Stock Option (right to buy) | |
| GE HealthCare Tech | Peter J. Arduini | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2023 | 39,425 | 81,245 | - | 0 | Common Stock, par value $0.01 per share | |
| GE HealthCare Tech | Peter J. Arduini | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 188,127 | 188,127 | - | - | Employee Stock Option (right to buy) | |
| GE HealthCare Tech | Peter J. Arduini | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 21,425 | 41,820 | - | 0 | Common Stock, par value $0.01 per share | |
| Bristol-Myers Squibb | Peter J. Arduini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2023 | 2,807 | 43,617 | - | - | Deferred Share Units | |
| GE HealthCare Tech | Peter J. Arduini | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2023 | 89,023 | 89,023 | - | - | Employee Stock Option (right to buy) | |
| GE HealthCare Tech | Peter J. Arduini | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2023 | 20,395 | 20,395 | - | - | Restricted Stock Units | |
| Bristol-Myers Squibb | Peter J. Arduini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2022 | 469 | 40,485 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb | Peter J. Arduini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2022 | 474 | 39,740 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb | Peter J. Arduini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2022 | 438 | 38,979 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb | Peter J. Arduini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 462 | 38,266 | - | - | Deferred Share Units | |
| GE Aerospace | Peter J. Arduini | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 63,044 | 63,044 | - | - | Employee Stock Option (right to buy) | |
| GE Aerospace | Peter J. Arduini | Senior Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2022 | 14,443 | 14,443 | - | - | Restricted Stock Units | |
| Bristol-Myers Squibb | Peter J. Arduini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2022 | 3,067 | 37,803 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb | Peter J. Arduini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2021 | 521 | 34,450 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb | Peter J. Arduini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Sep 2021 | 549 | 33,648 | - | - | Deferred Share Units | |
| Integra Lifesciences Holdings | Peter J. Arduini | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 75.97 per share. | 02 Sep 2021 | 71,829 | 216,713 (0%) | 0% | 76.0 | 5,456,662 | Common Stock |
| Integra Lifesciences Holdings | Peter J. Arduini | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.88 per share. | 02 Sep 2021 | 71,829 | 288,542 (0%) | 0% | 20.9 | 1,499,790 | Common Stock |
| Integra Lifesciences Holdings | Peter J. Arduini | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2021 | 71,829 | 46,605 | - | - | Non-Qualified Stock Option (right to buy) | |
| Integra Lifesciences Holdings | Peter J. Arduini | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.88 per share. | 02 Sep 2021 | 46,605 | 263,318 (0%) | 0% | 20.9 | 973,112 | Common Stock |
| Integra Lifesciences Holdings | Peter J. Arduini | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Sep 2021 | 46,605 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Integra Lifesciences Holdings | Peter J. Arduini | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 75.75 per share. | 02 Sep 2021 | 46,605 | 216,713 (0%) | 0% | 75.8 | 3,530,459 | Common Stock |
| Bristol-Myers Squibb | Peter J. Arduini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2021 | 507 | 32,862 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb | Peter J. Arduini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2021 | 574 | 32,111 | - | - | Deferred Share Units | |
| Integra Lifesciences Holdings | Peter J. Arduini | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2021 | 66,402 | 66,402 | - | - | Non-Qualified Stock Option (right to buy) | |
| Integra Lifesciences Holdings | Peter J. Arduini | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2021 | 22,027 | 553,614 | - | - | Restricted Stock Units | |
| Integra Lifesciences Holdings | Peter J. Arduini | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.10 per share. | 12 Mar 2021 | 368 | 216,713 (0%) | 0% | 68.1 | 25,061 | Common Stock |
| Integra Lifesciences Holdings | Peter J. Arduini | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2021 | 368 | 217,081 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdings | Peter J. Arduini | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2021 | 368 | 552,716 | - | - | Restricted Stock Units | |
| Integra Lifesciences Holdings | Peter J. Arduini | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.10 per share. | 12 Mar 2021 | 272 | 216,713 (0%) | 0% | 68.1 | 18,523 | Common Stock |
| Integra Lifesciences Holdings | Peter J. Arduini | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2021 | 272 | 216,985 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdings | Peter J. Arduini | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2021 | 272 | 553,084 | - | - | Restricted Stock Units | |
| Integra Lifesciences Holdings | Peter J. Arduini | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.10 per share. | 12 Mar 2021 | 258 | 216,713 (0%) | 0% | 68.1 | 17,570 | Common Stock |
| Integra Lifesciences Holdings | Peter J. Arduini | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2021 | 258 | 216,971 (0%) | 0% | 0 | Common Stock | |
| Integra Lifesciences Holdings | Peter J. Arduini | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Mar 2021 | 258 | 553,356 | - | - | Restricted Stock Units | |
| Integra Lifesciences Holdings | Peter J. Arduini | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.79 per share. | 01 Feb 2021 | 22,786 | 239,499 (0%) | 0% | 15.8 | 359,791 | Common Stock |
| Integra Lifesciences Holdings | Peter J. Arduini | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2021 | 22,786 | 0 | - | - | Non-Qualified Stock Option (right to buy) | |
| Integra Lifesciences Holdings | Peter J. Arduini | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 66.16 per share. | 01 Feb 2021 | 22,786 | 216,713 (0%) | 0% | 66.2 | 1,507,442 | Common Stock |
| Bristol-Myers Squibb | Peter J. Arduini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 3,054 | 31,537 | - | - | Deferred Share Units | |
| Bristol-Myers Squibb | Peter J. Arduini | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Dec 2020 | 584 | 28,260 | - | - | Deferred Share Units | |
| Integra Lifesciences Holdings | Peter J. Arduini | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Dec 2020 | 45,000 | 22,786 | - | - | Non-Qualified Stock Option (right to buy) | |
| Integra Lifesciences Holdings | Peter J. Arduini | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 15.79 per share. | 18 Dec 2020 | 45,000 | 261,713 (0%) | 0% | 15.8 | 710,550 | Common Stock |
| Integra Lifesciences Holdings | Peter J. Arduini | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 61.97 per share. | 18 Dec 2020 | 45,000 | 216,713 (0%) | 0% | 62.0 | 2,788,781 | Common Stock |